THEVAPESTOP LIMITED

Company Registration Number:
15459490 (England and Wales)

Unaudited micro entity accounts for the year ended 28 February 2025

Period of accounts

Start date: 01 February 2024

End date: 28 February 2025

THEVAPESTOP LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

THEVAPESTOP LIMITED

Company Information

for the Period Ended 28 February 2025




Director: AUDRIUS RAUDONIS
Registered office: 23
Glenthorpe Terrace
Leeds
England
LS9 7QS
Company Registration Number: 15459490 (England and Wales)

THEVAPESTOP LIMITED

Directors' Report Period Ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Directors

The directors shown below have held office during the whole of the period from 01 February 2024 to 28 February 2025
AUDRIUS RAUDONIS

This report was approved by the board of directors on 17 March 2025
And Signed On Behalf Of The Board By:

Name: AUDRIUS RAUDONIS
Status: Director

THEVAPESTOP LIMITED

Profit and Loss Account

for the Period Ended 28 February 2025

13 months to
28 Feb 2025
£
Turnover 67,596
Staff Costs ( 34,700 )
Other charges ( 31,664 )
Profit or (Loss) for Period 1,232

THEVAPESTOP LIMITED

Balance sheet

As at 28 February 2025

13 months to
28 Feb 2025
£
Current assets: 0
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Total net assets (liabilities): 0
Capital and reserves: 0

THEVAPESTOP LIMITED

Balance sheet continued

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 17 March 2025
And Signed On Behalf Of The Board By:

Name: AUDRIUS RAUDONIS
Status: Director

The notes form part of these financial statements

THEVAPESTOP LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Employee Information

    Average number of employees: 1

THEVAPESTOP LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Off balance sheet disclosure

    No